Development of an Immunoassay Platform Targeting β-1,3- and β-1,6-Glucans for Rapid Detection of Fungi
Journal of Fungi · 19.06.2026 · 12 (6) · 448
DOI: 10.3390/jof12060448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fungi, online erschienen am 19.06.2026. Verfasst von Wei Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, National Key Research and Development Program of China.
Abstract (Originalsprache)
Fungal infections pose diagnostic challenges in both human and veterinary medicine, as traditional detection methods such as fungal culture are time-consuming, microscopy is operator-dependent, and molecular detection assays often require specialized instrumentation and trained personnel, which can limit their routine clinical application. This study developed a sandwich immunoassay to detect β-1,3- and β-1,6-glucans, two major components of the fungal cell wall, based on two catalytically inactive glucanase mutants, LamAE175Q and Neg1E321Q. The sandwich ELISA exhibited higher detection sensitivity than conventional ITS-based PCR for Saccharomyces cerevisiae and Candida albicans under the conditions of this study. Using pre-coated plates, the sample-processing and detection workflow can be completed in approximately 40 min. It effectively detected a wide range of fungal species, including yeasts (Saccharomyces cerevisiae, Candida albicans) and filamentous fungi such as dermatophytes and non-dermatophyte molds. In a preliminary clinical cohort, the assay identified β-glucan signals in all 21 samples confirmed positive for dermatophytes, while no signal was detected in 20 negative samples, suggesting potential clinical applicability. This dual-enzyme sandwich immunoassay provides a rapid and low-cost complementary tool for broad-spectrum fungal screening, which may help guide further confirmatory diagnostics and timely clinical decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
- China Agricultural University Veterinary Teaching Hospital, Beijing 100193, China.
- Teaching Animal Hospital, China Agricultural University, Beijing 100193, China.
ORCID-Profile: Yueping Zhang
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- National Key Research and Development Program of China
- Talent Fund of China Agricultural University Veterinary Teaching Hospital
- Beijing Zhongnongda Veterinary Hospital Co., Ltd.
Zitieren
APA
Yuan, W., Chen, Z., Gao, Y., Jin, C., Yang, Z., Zhu, W., Zhang, D., & Zhang, Y. (2026). Development of an Immunoassay Platform Targeting β-1,3- and β-1,6-Glucans for Rapid Detection of Fungi. Journal of Fungi, 12(6), 448. https://doi.org/10.3390/jof12060448
Vancouver
Yuan W, Chen Z, Gao Y, Jin C, Yang Z, Zhu W, et al. Development of an Immunoassay Platform Targeting β-1,3- and β-1,6-Glucans for Rapid Detection of Fungi. Journal of Fungi. 2026;12(6):448. doi:10.3390/jof12060448
BibTeX
@article{Yuan2026,
author = {Yuan, Wei and Chen, Zan and Gao, Yingyin and Jin, Changbin and Yang, Zhibo and Zhu, Wenzhuang and Zhang, Di and Zhang, Yueping},
title = {Development of an Immunoassay Platform Targeting β-1,3- and β-1,6-Glucans for Rapid Detection of Fungi},
journal = {Journal of Fungi},
year = {2026},
volume = {12},
number = {6},
pages = {448},
doi = {10.3390/jof12060448}
}
EUVIMED